2024 Here we go again., page-435

There was an excellent post years ago re Meso being a growth stock, not a dividend paying stock . From memory it had to do with
most earnings being US based vs typical Aussie mining/banking stocks with earnings on shore. Perhaps someone has it stashed away somewhere?

As for my calling $50 - it was in response to investing elsewhere - I see so much potential here that I won't be deterred until we get answers on CHF and am hopeful of an approval in pediatric aGvHD/ with adults close behind.

I only place a simplistic valuation on aGvHD without the multitude of inputs from running sales teams/ taxes/ R&D, growth forecasts/ market penetration etc until we get pricing agreed to.

Sales 1 Billion. zero allowed for off label
Profit $300 million

Earnings multiple 30

9 Billion / 1.1 Billion shares

$8.18 for our smallest indication


The market size is factual
The need is unmet
Just need pricing
oh - and an approval would be nice



Reg